Page last updated: 2024-08-24

venlafaxine hydrochloride and escitalopram

venlafaxine hydrochloride has been researched along with escitalopram in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's7 (100.00)2.80

Authors

AuthorsStudies
Haas, DM; Marks, C; Quinney, SK; Silvola, R; Teal, E1
Koziorowski, M; Mytych, J; Sołek, P; Tabęcka-Łonczyńska, A1
Chen, J; Lan, X; Lao, G; Li, G; Li, W; Ning, Y; Wang, C; Wu, K; Zhang, M; Zhang, Z; Zhou, Y1
Cipelli, R; Dell'Osso, B; Di Nicola, M; Martinotti, G; Peduto, I; Pugliese, AC; Signorelli, MS; Ventriglio, A1
Cao, Q; Rao, Y; Yang, R; Zhao, J1
Haugen, F; Kaplan-Arabaci, O; Kondratskaya, E; Paulsen, RE; Zosen, D1
Bhatele, P; Chand Sarangi, S; Dwivedi, R; Elavarasi, A; Kalaivani, M; Kumar Singh, R; Prarthana Chandra, P; Sagar, R; Tripathi, M; Vibha, D1

Reviews

1 review(s) available for venlafaxine hydrochloride and escitalopram

ArticleYear
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2022, Aug-01, Volume: 51, Issue:4

    Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride

2022

Trials

1 trial(s) available for venlafaxine hydrochloride and escitalopram

ArticleYear
VE-MMODE - A randomized controlled trial of Venlafaxine versus Escitalopram for treatment of mild to moderate depression in persons with epilepsy.
    Epilepsy & behavior : E&B, 2023, Volume: 145

    Topics: Adolescent; Depression; Double-Blind Method; Epilepsy; Escitalopram; Humans; Seizures; Treatment Outcome; Venlafaxine Hydrochloride

2023

Other Studies

5 other study(ies) available for venlafaxine hydrochloride and escitalopram

ArticleYear
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study.
    Pharmacotherapy, 2021, Volume: 41, Issue:11

    Topics: Antidepressive Agents; Bupropion; Citalopram; Duloxetine Hydrochloride; Escitalopram; Female; Fluoxetine; Humans; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

2021
Molecular Consequences of Depression Treatment: A Potential In Vitro Mechanism for Antidepressants-Induced Reprotoxic Side Effects.
    International journal of molecular sciences, 2021, Nov-01, Volume: 22, Issue:21

    Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Cell Line; Escitalopram; Fluoxetine; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation; Imipramine; Male; Mice; Micronuclei, Chromosome-Defective; Mirtazapine; Models, Biological; Olanzapine; Organ Specificity; Reboxetine; Reproduction; Signal Transduction; Spermatogenesis; Telomeric Repeat Binding Protein 1; Telomeric Repeat Binding Protein 2; Time Factors; Venlafaxine Hydrochloride

2021
Predictors of 4-week antidepressant outcome in patients with first-episode major depressive disorder: An ROC curve analysis.
    Journal of affective disorders, 2022, 05-01, Volume: 304

    Topics: Antidepressive Agents; Depressive Disorder, Major; Escitalopram; Humans; ROC Curve; Treatment Outcome; Venlafaxine Hydrochloride

2022
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy.
    Current neuropharmacology, 2023, Volume: 21, Issue:3

    Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Humans; Italy; Paroxetine; Retrospective Studies; Sertraline; Venlafaxine Hydrochloride; Vortioxetine

2023
Antidepressants escitalopram and venlafaxine up-regulate BDNF promoter IV but down-regulate neurite outgrowth in differentiating SH-SY5Y neurons.
    Neurochemistry international, 2023, Volume: 169

    Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Line, Tumor; Child; Escitalopram; Female; Humans; Neuroblastoma; Neuronal Outgrowth; Neurons; Pregnancy; Venlafaxine Hydrochloride

2023